| Variable |
n |
Adverse event (n) |
Rate of adverse event (%) |
Odds ratio (95% CI; p-value) |
| Age |
|
|
|
|
| <12 months |
25 |
19 |
76 |
1 |
| 13 months – 5 years |
52 |
18 |
35 |
0.17 (0.06-0.49; 0.0012) |
| 5-18 years |
40 |
10 |
25 |
0.10 (0.03-0.34; 0.0001) |
| Weight |
|
|
|
|
| <5 kg |
14 |
11 |
79 |
1 |
| 6-10 kg |
21 |
10 |
48 |
0.24 (0.05-1.15; p=0.08) |
| 11-20 kg |
55 |
18 |
33 |
0.13 (0.03-0.53; p=0.005) |
| >21 kg |
13 |
8 |
62 |
0.12 (0.03-0.53; p=0.0053) |
| PAH |
|
|
|
|
| Yes |
58 |
30 |
52 |
1 |
| No |
54 |
17 |
31 |
0.43 (0.20-0.93; p=0.03) |
| Qp:Qs |
|
|
|
|
| 1-1.5 |
12 |
5 |
42 |
1 |
| 1.6-2.0 |
10 |
2 |
20 |
0.35 (0.05-2.4; p=0.28) |
| 2.1-4.0 |
15 |
6 |
40 |
0.93 (0.19-4.4; p=0.93) |
| 4.1-6.0 |
2 |
1 |
50 |
1.4 (0.07-28.1; p=0.83) |
| >6.1 |
1 |
1 |
100 |
4 (0.13-120.7; p=0.41) |
| PVR |
|
|
|
|
| 0.5-1.5 |
7 |
1 |
14 |
1 |
| 1.6-3.0 |
6 |
1 |
17 |
1.2 (0.05-24.5; p=0.91) |
| 3.1-4.5 |
9 |
3 |
33 |
3 (0.24-37.7; p=0.85) |
| 4.6-6.0 |
3 |
1 |
33 |
3 (0.24-37.7; p=0.85) |
| >6.0 |
2 |
2 |
100 |
21.7 (0.64-730.1; p=0.09) |
| Duration of stay in ICU/SICU |
|
|
|
|
| 0-4 days |
81 |
20 |
23 |
1 |
| 5-7 days |
24 |
19 |
79 |
11.6 (3.83-35.1; p<0.0001) |
| >8 days |
12 |
8 |
67 |
6.1 (1.7-22.4; p=0.0065) |
| VSD Type |
|
|
|
|
| Perimembranous |
75 |
27 |
36 |
1 |
| Muscular |
10 |
5 |
33 |
1.7 (0.47-6.70; p=0.39) |
| Inlet |
4 |
4 |
100 |
15.8 (0.82-306.0; p=0.07) |
| Supracristal VSD |
25 |
9 |
36 |
1 (0.39-2.57; p=1.0) |
| Gerbodes |
1 |
0 |
0 |
0.58 (0.02-14.9; p=0.74) |
| Number of VSDs |
|
|
|
|
| Single |
108 |
44 |
41 |
1 |
| Multiple |
7 |
3 |
43 |
1.1 (0.23-5.11; p=0.11) |
| Size of VSD |
|
|
|
|
| Small |
23 |
4 |
17 |
1 |
| Medium |
32 |
17 |
53 |
5.4 (1.5-19.4; p=0.01) |
| Large |
40 |
18 |
45 |
3.9 (1.11-13.5; p=0.03) |
| Associated defects |
|
|
|
|
| Yes |
76 |
28 |
37 |
1 |
| No |
41 |
19 |
46 |
1.5 (0.68-3.1; p=0.32) |
| PS |
11 |
5 |
45 |
1 |
| ASD |
13 |
7 |
54 |
1.4 (0.27-7.0; p=0.68) |
| PDA |
15 |
8 |
53 |
1.37 (0.39-6.6; p=0.69) |
| MR |
20 |
6 |
30 |
0.51 (0.11-2.4; p=0.39) |
| MS |
1 |
0 |
0 |
0.39 (0.01-11.8; p=0.59) |
| COA |
2 |
1 |
50 |
1.2 (0.06-24.5; p=0.12) |
| AS |
2 |
0 |
0 |
0.24 (0.009-6.0; p=0.38) |
| AR |
30 |
10 |
33 |
0.60 (0.15-5.6; p=0.48) |
| Prolapse of coronary cusp |
35 |
10 |
29 |
0.48 (0.12-1.94; p=0.30) |
